Research programme: Ebola virus vaccine - Soligenix/Hawaii Biotech/University of Hawaii

Drug Profile

Research programme: Ebola virus vaccine - Soligenix/Hawaii Biotech/University of Hawaii

Latest Information Update: 20 Jul 2016

Price : $50

At a glance

  • Originator Hawaii Biotech; Soligenix; University of Hawaii
  • Class Viral vaccines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Ebola virus infections

Most Recent Events

  • 18 Jul 2016 Preclinical trials in Ebola virus infections in USA (Parenteral)
  • 28 May 2015 Early research in Ebola virus infections in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top